Updated July-2026-25

Does Medicare Cover Eliquis? Coverage Rules, Cost & Appeals for 2026

Evan Brown
Written by Evan Brown
Medical Content Researcher
Dr Megan Harris Medically Reviewed by Dr. Megan Harris, MD
Editorial Review: This guide answers whether Medicare covers Eliquis, explains how Medicare Part D's 2026 cost structure works, and walks through what to do if your specific plan denies coverage. Every regulatory claim below links directly to the official government or manufacturer source it's based on.
Quick Answer

Original Medicare (Part A and Part B) does not cover Eliquis. Coverage depends entirely on having a Medicare Part D prescription drug plan, either standalone or bundled into a Medicare Advantage (MA-PD) plan, and that specific plan must include Eliquis on its formulary. Most Part D plans do cover Eliquis, since it's one of the most widely prescribed anticoagulants for atrial fibrillation and blood clot treatment among Medicare-age patients. As of 2026, Part D plans cap total annual out-of-pocket drug costs at $2,100, per the CMS Part D redesign, after which the plan pays 100% for the rest of the year. Unlike the manufacturer copay card, which Medicare patients cannot use, Part D coverage or Extra Help are the paths that actually apply to you.

Key Takeaways

  • Original Medicare alone never covers Eliquis — you need Part D or a Medicare Advantage plan with drug coverage.
  • Most Part D formularies include Eliquis, but tier placement and cost-sharing vary by plan.
  • The 2026 Part D out-of-pocket cap is $2,100, not the $2,000 figure from 2025.
  • The Eliquis manufacturer copay card cannot be used with Medicare due to federal anti-kickback restrictions.
  • Denials can be appealed through Medicare's formal five-level Part D appeals process.

If you've just been prescribed Eliquis (apixaban) and you're on Medicare, the coverage question isn't as simple as "yes" or "no." It depends on which parts of Medicare you have, which specific Part D or Medicare Advantage plan you're enrolled in, and what tier that plan places Eliquis on.

Eliquis is one of the most commonly prescribed blood thinners for people 65 and older, used to reduce stroke risk in atrial fibrillation and to treat or prevent blood clots. Because of how common it is among Medicare beneficiaries specifically, most Part D formularies include it — but "most" isn't "all," and cost-sharing can vary significantly between plans.

This guide explains exactly how Medicare drug coverage works for Eliquis, what it actually costs under the 2026 rules, how to check your specific plan, and what your options are — including the manufacturer's separate cash-pay program — if coverage or cost becomes a problem.

Table of Contents

  1. The Short Answer, Explained
  2. Original Medicare vs Part D vs Medicare Advantage
  3. How Much Eliquis Costs Under Medicare in 2026
  4. The $2,100 Out-of-Pocket Cap, Explained
  5. How to Check If Your Plan Covers Eliquis
  6. Why You Can't Use the Manufacturer Copay Card
  7. Extra Help and the Low-Income Subsidy
  8. Prior Authorization and Step Therapy for Eliquis
  9. What to Do If Your Plan Denies Coverage
  10. Frequently Asked Questions

The Short Answer, Explained

Medicare coverage for Eliquis comes down to three separate questions.

Question What Determines the Answer
Do I have drug coverage at all? Requires Part D or Medicare Advantage with drug benefits (MA-PD)
Does my specific plan cover Eliquis? Depends on that plan's individual formulary — check via the official Medicare Plan Finder
What will I actually pay? Depends on the plan's formulary tier for Eliquis and where you are in the 2026 cost-phase structure

The most common mistake: Assuming that having "Medicare" automatically means having drug coverage. If you only have Original Medicare Part A and Part B with no Part D plan attached, Eliquis isn't covered at all.

Original Medicare vs Part D vs Medicare Advantage

Medicare Type Covers Eliquis? Why
Original Medicare Part A only Never Hospital coverage only, no prescription drug benefit
Original Medicare Part B only Never Covers medical services and some physician-administered drugs, not self-administered pills
Standalone Part D Plan Usually Most Part D formularies include Eliquis, but confirm your specific plan
Medicare Advantage with Drug Coverage (MA-PD) Usually Same formulary logic as standalone Part D plans
Medicare Advantage without Drug Coverage Never No Part D benefit attached — check your plan's benefit summary

Not all Medicare Advantage plans include drug coverage. Confirm your plan's specific benefits directly rather than assuming Medicare Advantage automatically means Part D is included.

How Much Eliquis Costs Under Medicare in 2026

Assuming your plan covers Eliquis, your actual out-of-pocket cost depends on which phase of the Part D benefit year you're in.

Phase What Happens
Deductible Phase You pay toward your plan's deductible (if it has one) before coverage kicks in
Initial Coverage Phase You pay your plan's copay or coinsurance for Eliquis based on its formulary tier
Catastrophic Phase Once your total out-of-pocket spending hits $2,100 for the year, the plan pays 100% of costs for covered drugs for the remainder of the year

Eliquis is frequently placed on a preferred brand tier rather than a specialty tier, which generally means lower cost-sharing than a specialty drug — but exact copay amounts still vary significantly between plans, so check your formulary directly.

The $2,100 Out-of-Pocket Cap, Explained

Since the Inflation Reduction Act's Part D redesign took effect in 2025, the old "coverage gap" or donut hole system no longer exists. The cap started at $2,000 in 2025 and rose to $2,100 for 2026, adjusted annually based on drug spending trends, according to the CMS 2026 Part D Redesign Program Instructions.

Old System (Pre-Redesign) Current System (2025 Onward)
Multiple phases including a "donut hole" with different cost-sharing Simplified phases ending in a hard annual cap
No true annual out-of-pocket maximum for many patients $2,100 annual out-of-pocket cap on covered Part D drugs (2026)
Costs could spike unpredictably mid-year Costs become $0 once the cap is reached for the rest of the year

Why this matters for Eliquis specifically: Because many Medicare beneficiaries take Eliquis long-term alongside other maintenance medications, it's often one of several drugs that collectively push a patient toward the $2,100 cap earlier in the year — after which all covered Part D medications, including Eliquis refills, become free for the rest of that calendar year.

Medicare Prescription Payment Plan (Cost Smoothing)

Medicare also offers an optional payment plan that lets you spread your out-of-pocket drug costs into smaller monthly installments across the year instead of paying larger amounts upfront early in the year. This doesn't reduce your total cost, but it can make budgeting easier if you fill several expensive prescriptions at once.

How to Check If Your Plan Covers Eliquis

1

Use Medicare's official Plan Finder tool

Search for Eliquis specifically at medicare.gov/plan-compare and compare formulary status, tier, and estimated cost across plans available in your area.

2

Call your specific plan directly

Ask whether Eliquis is on the formulary, what tier it's placed on, and whether prior authorization or step therapy applies.

3

Ask your pharmacist to run a test claim

A test claim at the pharmacy can quickly reveal whether the medication processes under your current plan before you commit to a full fill.

4

Review your plan during Open Enrollment if needed

If your current plan places Eliquis on a high-cost tier, Medicare's annual Open Enrollment period is the time to switch to a plan with better formulary placement.

Decision Tree: Figuring Out Your Coverage

Step 1: Do you have a Part D plan or Medicare Advantage plan with drug coverage?

✔ Yes → Continue to Step 2.

✖ No → Eliquis isn't covered under Original Medicare alone; you'd need to enroll in Part D or a Medicare Advantage plan with drug benefits.


Step 2: Is Eliquis on your specific plan's formulary?

✔ Yes → Continue to Step 3.

✖ No → Check other plans during Open Enrollment, or ask your provider about a formulary exception.


Step 3: Is the copay still too high even with coverage?

✔ Yes → Check whether you qualify for Extra Help, or ask about the Eliquis 360 Support cash-pay option.

✖ No → You're set — fill your prescription as prescribed.


Why You Can't Use the Manufacturer Copay Card

Bristol Myers Squibb and Pfizer offer a commercial copay card through Eliquis 360 Support, but federal anti-kickback rules generally prohibit manufacturers from offering copay assistance to patients in government healthcare programs, including Medicare.

Program Medicare Beneficiaries Eligible?
Eliquis Copay Card No — federal restriction
Eliquis 360 Support Direct-to-Patient Cash-Pay Option Yes — available regardless of insurance status
Standard Part D Coverage Yes, if Eliquis is on your plan's formulary
Extra Help (Low-Income Subsidy) Yes, if income-eligible

Bristol Myers Squibb and Pfizer's direct-to-patient cash-pay option through Eliquis 360 Support is open to Medicare beneficiaries specifically because it isn't a copay assistance program tied to insurance billing — it's a straightforward cash purchase at a discounted list price, which sidesteps the federal restriction that blocks the copay card.

Extra Help and the Low-Income Subsidy

Medicare's Extra Help program, also called the Part D Low-Income Subsidy, can significantly reduce Part D costs for qualifying beneficiaries, including premiums, deductibles, and copays for covered drugs like Eliquis. You can apply directly through the Social Security Administration.

Feature What It Does
Premium Assistance Reduces or eliminates your Part D monthly premium
Deductible Reduction Lowers or removes your plan's annual deductible
Copay Reduction Caps your copay for covered drugs at a set, lower amount

If you qualify for Extra Help, your Eliquis copay can be dramatically lower than a beneficiary paying standard Part D cost-sharing, even before factoring in the $2,100 annual cap.


Prior Authorization and Step Therapy for Eliquis

Some Part D plans apply utilization management rules to Eliquis, particularly plans that prefer a lower-cost anticoagulant on their formulary.

Restriction Type What It Means
Prior Authorization Plan requires clinical documentation before approving coverage
Step Therapy Plan may require trying a different anticoagulant first, or documentation of why Eliquis is specifically needed
Quantity Limits Plan may cap the number of tablets covered per fill

Because Eliquis is such a widely used and well-established anticoagulant, many Part D plans place it as a preferred option without heavy restrictions — but this varies by plan, so don't assume yours is restriction-free without checking.


What to Do If Your Plan Denies Coverage

A denial from your Medicare plan isn't the final word. Medicare has a formal, five-level process for challenging a coverage decision, detailed on the official Medicare Part D appeals page.

1

Request a coverage determination

If your plan hasn't yet made a formal decision, ask your plan or provider to submit a coverage determination request — Medicare's term for an initial prior authorization decision.

2

File a redetermination if denied

If the coverage determination is denied, you or your provider can request a redetermination — the first formal appeal level — generally within 65 days of the denial notice.

3

Escalate through the remaining appeal levels if needed

If the plan upholds its denial, the case can move to an Independent Review Entity, then an Administrative Law Judge hearing, the Medicare Appeals Council, and finally federal district court if the disputed amount qualifies.

For a full breakdown of the Medicare Advantage appeals process at every level, see our guide: Humana Prior Authorization, which walks through the same federal appeal structure that applies across Medicare insurers.


Common Mistakes That Cause Confusion or Denials

  • □ Assuming Original Medicare alone provides drug coverage.
  • □ Assuming every Medicare Advantage plan automatically includes drug benefits.
  • □ Trying to use the manufacturer copay card while enrolled in Medicare.
  • □ Not checking the specific plan's formulary tier before assuming a low copay.
  • □ Missing the redetermination appeal deadline after a denial.
  • □ Not asking about Extra Help eligibility before assuming standard cost-sharing applies.
  • □ Waiting until mid-year to compare plans instead of using Open Enrollment.

Most Medicare coverage confusion traces back to not distinguishing between the different "parts" of Medicare, or assuming a commercial-insurance program like the copay card will work the same way under a federal health plan.


Quick Checklist for Medicare Beneficiaries

Checklist Item Status
Confirmed you have Part D or MA-PD (not Original Medicare alone)
Verified Eliquis is on your specific plan's formulary
Checked your plan's tier and estimated copay for Eliquis
Checked Extra Help eligibility if income is limited
Confirmed you're not relying on the manufacturer copay card
Noted the redetermination deadline if previously denied

Bottom Line

Medicare covers Eliquis through Part D or a Medicare Advantage plan that includes drug benefits — Original Medicare alone never covers it. Most Part D formularies do include Eliquis, given how common it is among Medicare-age patients, but tier placement and cost-sharing still vary by plan. The 2026 $2,100 annual out-of-pocket cap is meaningful protection for beneficiaries taking Eliquis long-term alongside other maintenance medications.

The manufacturer's copay card isn't an option for Medicare beneficiaries, but the Eliquis 360 Support direct-to-patient cash-pay option, Extra Help, and standard Part D coverage together cover almost every realistic scenario. If your plan denies coverage, the Medicare appeals process — starting with a redetermination request — gives you a real path to challenge that decision.


Frequently Asked Questions

Original Medicare Part A and Part B do not cover Eliquis, since it is a self-administered oral prescription drug. Coverage depends on having a Medicare Part D prescription drug plan or a Medicare Advantage plan that includes drug coverage, and Eliquis must be on that specific plan's formulary.

Cost depends on your plan's deductible and formulary tier for Eliquis, but total out-of-pocket drug spending across all Part D covered medications is capped at $2,100 in 2026, after which the plan covers 100% of costs for the rest of the year.

No. Federal anti-kickback rules generally prohibit manufacturer copay cards from being used by Medicare beneficiaries. Medicare patients should instead rely on their Part D plan's coverage, Extra Help if eligible, or the Eliquis 360 Support direct-to-patient cash-pay option.

Some Medicare Part D plans place step therapy or prior authorization requirements on Eliquis, especially on non-preferred formulary tiers, though many plans cover it without extensive restrictions given how common atrial fibrillation and blood clot treatment are among Medicare beneficiaries.

You can request a coverage determination from your plan, and if denied, file an appeal called a redetermination, which can escalate through several additional levels of Medicare's formal Part D appeals process if needed.

No. Not every Medicare Advantage plan includes drug coverage at all, and among those that do, formulary tier placement for Eliquis varies. Check your specific plan rather than assuming coverage based on having Medicare Advantage generally.

The old coverage gap system has been phased out under Part D's redesign. In its place is a simplified structure ending in a $2,100 annual out-of-pocket cap for 2026, after which covered medications are free for the rest of the calendar year.

Yes. Medicare's annual Open Enrollment period allows you to switch Part D or Medicare Advantage plans to one with better formulary placement for your specific medications, effective at the start of the next plan year.

Yes, if you qualify. Extra Help, also called the Low-Income Subsidy, can reduce or eliminate your Part D premium and deductible and cap your copay for covered drugs like Eliquis at a lower, set amount.

It's a cash-pay purchasing option offered by Bristol Myers Squibb and Pfizer that lets eligible patients, including Medicare beneficiaries, buy Eliquis directly at a discounted price shipped to their home, separate from insurance billing and the restricted copay card program.


How We Researched This Guide

This guide was prepared by the Refill Relay Editorial Team using official CMS Part D benefit design guidance, Medicare.gov program pages, the Social Security Administration's Extra Help materials, and Bristol Myers Squibb/Pfizer's official Eliquis 360 Support program information. Every regulatory and program claim in this article links directly to its official source below.

Every article undergoes editorial review for accuracy, readability, and consistency before publication. Our goal is to explain Medicare's prescription drug rules in clear language so beneficiaries can navigate coverage decisions with less confusion.


References

  1. Medicare.gov — What's Medicare Drug Coverage (Part D)?
  2. Medicare.gov — Your Health Plan Options (Medicare Advantage)
  3. CMS — Final CY 2026 Part D Redesign Program Instructions
  4. Medicare.gov — Help With Drug Costs (Extra Help)
  5. Social Security Administration — Apply for Medicare Part D Extra Help
  6. Medicare.gov — Appeals in a Medicare Drug Plan
  7. Medicare.gov — Medicare Plan Finder
  8. Eliquis 360 Support — Cost, Savings & Support Resources

About Refill Relay

Refill Relay publishes evidence-based educational resources that help patients understand prescription insurance, prior authorization requirements, pharmacy benefits and medication access. Our editorial team combines regulatory research with practical guidance to make complex healthcare topics easier to navigate.

Editorial Standards

  • Evidence-based regulatory research
  • Editorial review before publication
  • Regular updates when Medicare or CMS rules change
  • Clear distinction between educational content and medical or financial advice

Related Resources

Editorial Policy: Refill Relay content is researched using publicly available CMS guidance, Medicare.gov program materials, and manufacturer patient support resources. Every article is reviewed for clarity, accuracy and usefulness before publication.

Evan Brown
About the Author
Evan Brown — Medical Content Researcher

Evan Brown is a medical content researcher who specializes in translating complex Medicare and healthcare policy — including Part D benefit design — into clear, actionable guidance for patients.

View Full Profile →
Dr. Megan Harris, MD
Medical Review
Dr. Megan Harris, MD

Dr. Megan Harris, MD reviews health content for accuracy, checking eligibility criteria and Medicare coverage details against current CMS and FDA guidance.

View Full Profile →

Get Started with Refill Relay